Health news
The likelihood that a patient with cancer will receive guideline-concordant treatment varies according to cancer type, age, comorbidities, and center volume, according to a study published in Advances in Radiation Oncology. Researchers aimed to evaluate…
Radioiodine after thyroidectomy does not improve outcomes in patients with low-risk thyroid cancer, according to a phase 3 trial published in The New England Journal of Medicine. Researchers found no significant difference in functional, structural,…
Combination RP1 and nivolumab can produce durable responses in patients with non-melanoma skin cancer of the head and neck, according to research presented at the 2022 Multidisciplinary Head and Neck Cancers Symposium. RP1 is an…
A multimodal artificial intelligence (AI) platform can accurately identify thyroid cancer using routine ultrasound images, according to research presented at the 2022 Multidisciplinary Head and Neck Cancers Symposium.1 “We have developed an artificial intelligence platform…
The Food and Drug Administration (FDA) has granted Orphan Drug designation (ODD) to silmitasertib for the treatment of patients with medulloblastoma. Medulloblastoma is a rare, severe brain tumor of the cerebellum caused by gene mutations…
The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application for toripalimab, in combination with gemcitabine and cisplatin, for the first-line treatment of patients with advanced recurrent or metastatic nasopharyngeal…
An international survey has revealed barriers to accessing cancer drugs deemed essential for routine clinical care. The survey was published in The Lancet Oncology. Researchers surveyed medical oncologists from 82 countries and found that some…
Lockdowns and restrictions due to the COVID-19 pandemic led to delays in cancer surgeries, but this did not seem to affect short-term outcomes for most patients, according to a study published in The Lancet Oncology.…
The genomic-adjusted radiation dose (GARD) model can predict outcomes of radiotherapy in patients with cancer, according to results of a study published in The Lancet Oncology. In fact, GARD outperformed radiation dose for predicting time…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021